DrugDashboards
← Home
Manufacturing facility

Polypeptide

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
Belgium
Registered address
Chaussee de Tubize 297, Braine-I'Alleud, 1420, Belgium (BEL)
Operations here
analysisapi manufacture
FDA identifiers
FEI 3002808410 · DUNS 763929036

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2023-12-18
  • VAIDrug Quality Assurance2020-10-02
  • NAIDrug Quality Assurance2017-03-16
  • VAIDrug Quality Assurance2014-05-30
  • NAIDrug Quality Assurance2012-06-14
  • NAIDrug Quality Assurance2009-06-16

Drugs this plant is listed as making

1 distinct drugs across 1 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.